FDA Drug Shortage Strategy: Enforcement Discretion, Patient Public Relations
This article was originally published in The Pink Sheet Daily
Executive Summary
Rapid approval of a new, preservative-free generic methotrexate and permission to import an unapproved version of doxorubicin touted at press conference as FDA emphasizes the success of administrative efforts.